Related Experiment Videos
[Diffuse hair loss in women].
1Dermatologische Klinik, UniversitätsSpital Zürich.
Therapeutische Umschau. Revue Therapeutique
|July 2, 2002
Summary
Understanding hair loss in women is crucial for diagnosis and treatment. Differentiating between androgenetic alopecia, telogen effluvium, and psychogenic pseudo effluvium guides effective management strategies for various hair thinning conditions.
Area of Science:
- Dermatology and Trichology
- Endocrinology
- Psychology
Context:
- Diffuse hair loss in women presents diagnostic and therapeutic challenges.
- Female pattern hair loss is often linked to androgenetic alopecia, influenced by hormonal fluctuations or therapies.
- Distinguishing between androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium is critical.
Purpose:
- To outline the differential diagnosis of diffuse hair loss in women.
- To describe the mechanisms and characteristics of androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium.
- To guide physicians in selecting appropriate therapies based on accurate diagnosis.
Summary:
- Androgenetic alopecia involves androgen-induced hair cycle shortening, leading to central scalp thinning.
- Idiopathic chronic telogen effluvium is characterized by abrupt, widespread shedding due to hair growth cycle synchronization.
- Psychogenic pseudo effluvium stems from a perceived discrepancy between actual hair and idealized expectations.
Impact:
- Rational therapy for androgenetic alopecia includes anti-androgens or minoxidil to counteract androgen effects.
- Reassurance and understanding are key for women with idiopathic chronic telogen effluvium, emphasizing shedding over true loss.
- Accurate diagnosis improves patient anxiety management and therapeutic outcomes for hair loss conditions.